Clinical Trial Update: Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Seoul National University Hospital is evaluating whether levetiracetam is beneficial for patients with newly diagnosed glioblastom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN